Sequencing-Based Detection of Minimal Residual Disease Is Associated with Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Lymphoid Malignancies

被引：0
|
作者：
Herrera, Alex F. [1 ]
Kim, Haesook T. [1 ]
Faham, Malek [2 ]
Sun, Heather [3 ]
Sohani, Aliyah R. [4 ]
Alyea, Edwin P. [1 ]
Chen, Yi-Bin [5 ]
Cutler, Corey S. [1 ]
Ho, Vincent T. [1 ]
Koreth, John [6 ]
Nikiforow, Sarah [1 ]
Ritz, Jerome [6 ]
Rodig, Scott J.
Soiffer, Robert J. [6 ]
Antin, Joseph H. [1 ]
Armand, Philippe [6 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Sequenta Inc, San Francisco, CA USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Maasachusetts Gen Hosp, Boston, MA USA
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[6] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
    Kroeger, Nicolaus
    Miyamura, Koichi
    Bishop, Michael R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) : S94 - S100
  • [2] Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia
    Shimomura, Yoshimitsu
    Maruoka, Hayato
    Yabushita, Tomohiro
    Hashimoto, Hisako
    Ishikawa, Takayuki
    BLOOD, 2017, 130
  • [3] Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome
    Shapiro, Roman M.
    Kim, Dennis Dong Hwan
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (06) : 425 - 432
  • [4] Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Solarska, Iwona
    Nasilowska-Adamska, Barbara
    Bieniaszewska, Maria
    Zaucha, Jan Maciej
    Rzepecki, Piotr
    Sawicki, Waldemar
    Calbecka, Malgorzata
    Lech-Maranda, Ewa
    Marianska, Bozena
    Warzocha, Krzysztof
    BLOOD, 2009, 114 (22) : 1266 - 1266
  • [5] Quantitative Next-Generation Sequencing (NGS) Based Monitoring of Minimal Residual Disease (MRD) Predicts Imminent Relapse in Patients with Myeloid Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation
    Rautenberg, Christina
    Betz, Beate
    Wieczorek, Dagmar
    Hildebrandt, Barbara
    Nachtkamp, Kathrin
    Schuler, Esther
    Gattermann, Norbert
    Kobbe, Guido
    Haas, Rainer
    Schroeder, Thomas
    BLOOD, 2017, 130
  • [6] COMPARISON OF DIFFERENT STRATEGIES OF MINIMAL RESIDUAL DISEASE DETECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE LEUKEMIA
    Medeot, M.
    Alessandra, S.
    Tiribelli, M.
    Michelutti, A.
    Cavallin, M.
    Geromin, A.
    Oletti, E. Toff
    Candoni, A.
    Fanin, R.
    Patriarca, F.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S548 - S548
  • [7] Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation
    Takamatsu, Hiroyuki
    Murata, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Takezako, Naoki
    Ito, Shigeki
    Miyamoto, Toshihiro
    Yokoyama, Kenji
    Matsue, Kosei
    Sato, Tsutomu
    Kurokawa, Toshiro
    Yagi, Hideo
    Terasaki, Yasushi
    Ohata, Kinya
    Yoshida, Takashi
    Faham, Malek
    Nakao, Shinji
    BLOOD, 2015, 126 (23)
  • [8] OUTCOMES OF CHILDREN WITH HEMATOLOGIC MALIGNANCIES WHO RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AND POST-HCT MINIMAL RESIDUAL DISEASE
    Shah, Nirali
    Borowitz, Michael
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather
    Loeb, David
    Wayne, Alan
    Chen, Allen
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S98 - S98
  • [9] Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation
    Takamatsu, H.
    Takezako, N.
    Zheng, J.
    Moorhead, M.
    Carlton, V. E. H.
    Kong, K. A.
    Murata, R.
    Ito, S.
    Miyamoto, T.
    Yokoyama, K.
    Matsue, K.
    Sato, T.
    Kurokawa, T.
    Yagi, H.
    Terasaki, Y.
    Ohata, K.
    Matsumoto, M.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2503 - 2510
  • [10] Subsequent malignancies after allogeneic hematopoietic stem cell transplantation
    Gunduz, Mehmet
    Ozen, Mehmet
    Sahin, Ugur
    Toprak, Selami Kocak
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Beksac, Meral
    Ilhan, Osman
    Gurman, Gunhan
    Topcuoglu, Pervin
    CLINICAL TRANSPLANTATION, 2017, 31 (07)
12345